Literature DB >> 33467676

A Single Dose of Psilocybin Increases Synaptic Density and Decreases 5-HT2A Receptor Density in the Pig Brain.

Nakul Ravi Raval1,2, Annette Johansen1,2, Lene Lundgaard Donovan1,2, Nídia Fernandez Ros1, Brice Ozenne1,3, Hanne Demant Hansen1,4, Gitte Moos Knudsen1,2.   

Abstract

A single dose of psilocybin, a psychedelic and serotonin 2A receptor (5-HT2AR) agonist, may be associated with antidepressant effects. The mechanism behind its antidepressive action is unknown but could be linked to increased synaptogenesis and down-regulation of cerebral 5-HT2AR. Here, we investigate if a single psychedelic dose of psilocybin changes synaptic vesicle protein 2A (SV2A) and 5-HT2AR density in the pig brain. Twenty-four awake pigs received either 0.08 mg/kg psilocybin or saline intravenously. Twelve pigs (n = 6/intervention) were euthanized one day post-injection, while the remaining twelve pigs were euthanized seven days post-injection (n = 6/intervention). We performed autoradiography on hippocampus and prefrontal cortex (PFC) sections with [3H]UCB-J (SV2A), [3H]MDL100907 (5-HT2AR antagonist) and [3H]Cimbi-36 (5-HT2AR agonist). One day post psilocybin injection, we observed 4.42% higher hippocampal SV2A density and lowered hippocampal and PFC 5-HT2AR density (-15.21% to -50.19%). These differences were statistically significant in the hippocampus for all radioligands and in the PFC for [3H]Cimbi-36 only. Seven days post-intervention, there was still significantly higher SV2A density in the hippocampus (+9.24%) and the PFC (+6.10%), whereas there were no longer any differences in 5-HT2AR density. Our findings suggest that psilocybin causes increased persistent synaptogenesis and an acute decrease in 5-HT2AR density, which may play a role in psilocybin's antidepressive effects.

Entities:  

Keywords:  5-HT2A; SV2A; autoradiography; depression; functional-selectivity; neuroplasticity; psilocybin; psychedelics

Mesh:

Substances:

Year:  2021        PMID: 33467676      PMCID: PMC7830000          DOI: 10.3390/ijms22020835

Source DB:  PubMed          Journal:  Int J Mol Sci        ISSN: 1422-0067            Impact factor:   5.923


  43 in total

Review 1.  The neurobiology of psychedelic drugs: implications for the treatment of mood disorders.

Authors:  Franz X Vollenweider; Michael Kometer
Journal:  Nat Rev Neurosci       Date:  2010-08-18       Impact factor: 34.870

2.  Rapid modulation of spine morphology by the 5-HT2A serotonin receptor through kalirin-7 signaling.

Authors:  Kelly A Jones; Deepak P Srivastava; John A Allen; Ryan T Strachan; Bryan L Roth; Peter Penzes
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-04       Impact factor: 11.205

3.  Chronic administration of harmine elicits antidepressant-like effects and increases BDNF levels in rat hippocampus.

Authors:  Jucélia J Fortunato; Gislaine Z Réus; Tamires R Kirsch; Roberto B Stringari; Gabriel R Fries; Flávio Kapczinski; Jaime E Hallak; Antônio W Zuardi; José A Crippa; João Quevedo
Journal:  J Neural Transm (Vienna)       Date:  2010-08-05       Impact factor: 3.575

4.  Rapid agonist-induced internalization of the 5-hydroxytryptamine2A receptor occurs via the endosome pathway in vitro.

Authors:  S A Berry; M C Shah; N Khan; B L Roth
Journal:  Mol Pharmacol       Date:  1996-08       Impact factor: 4.436

5.  A High-Resolution In Vivo Atlas of the Human Brain's Serotonin System.

Authors:  Vincent Beliveau; Melanie Ganz; Ling Feng; Brice Ozenne; Liselotte Højgaard; Patrick M Fisher; Claus Svarer; Douglas N Greve; Gitte M Knudsen
Journal:  J Neurosci       Date:  2017-01-04       Impact factor: 6.167

6.  Distribution of the serotonin 5-HT2 receptor family mRNAs: comparison between 5-HT2A and 5-HT2C receptors.

Authors:  M Pompeiano; J M Palacios; G Mengod
Journal:  Brain Res Mol Brain Res       Date:  1994-04

7.  Psychedelic effects of psilocybin correlate with serotonin 2A receptor occupancy and plasma psilocin levels.

Authors:  Martin K Madsen; Patrick M Fisher; Daniel Burmester; Agnete Dyssegaard; Dea S Stenbæk; Sara Kristiansen; Sys S Johansen; Sczabolz Lehel; Kristian Linnet; Claus Svarer; David Erritzoe; Brice Ozenne; Gitte M Knudsen
Journal:  Neuropsychopharmacology       Date:  2019-01-26       Impact factor: 7.853

8.  Preclinical safety assessment of the 5-HT2A receptor agonist PET radioligand [ 11C]Cimbi-36.

Authors:  Anders Ettrup; Søren Holm; Martin Hansen; Muhammad Wasim; Martin Andreas Santini; Mikael Palner; Jacob Madsen; Claus Svarer; Jesper Langgaard Kristensen; Gitte Moos Knudsen
Journal:  Mol Imaging Biol       Date:  2013-08       Impact factor: 3.488

9.  Receptor interaction profiles of novel psychoactive tryptamines compared with classic hallucinogens.

Authors:  Anna Rickli; Olivier D Moning; Marius C Hoener; Matthias E Liechti
Journal:  Eur Neuropsychopharmacol       Date:  2016-05-20       Impact factor: 4.600

Review 10.  Hunting for the high-affinity state of G-protein-coupled receptors with agonist tracers: Theoretical and practical considerations for positron emission tomography imaging.

Authors:  Vladimir Shalgunov; Aren van Waarde; Jan Booij; Martin C Michel; Rudi A J O Dierckx; Philip H Elsinga
Journal:  Med Res Rev       Date:  2018-11-18       Impact factor: 12.944

View more
  16 in total

Review 1.  New Paradigms of Old Psychedelics in Schizophrenia.

Authors:  Danish Mahmood; Sattam K Alenezi; Md Jamir Anwar; Faizul Azam; Kamal A Qureshi; Mariusz Jaremko
Journal:  Pharmaceuticals (Basel)       Date:  2022-05-23

Review 2.  Psychedelic-inspired approaches for treating neurodegenerative disorders.

Authors:  Hannah N Saeger; David E Olson
Journal:  J Neurochem       Date:  2021-12-05       Impact factor: 5.546

Review 3.  Biochemical Mechanisms Underlying Psychedelic-Induced Neuroplasticity.

Authors:  David E Olson
Journal:  Biochemistry       Date:  2022-01-21       Impact factor: 3.162

4.  Psilocybin induces rapid and persistent growth of dendritic spines in frontal cortex in vivo.

Authors:  Ling-Xiao Shao; Clara Liao; Ian Gregg; Pasha A Davoudian; Neil K Savalia; Kristina Delagarza; Alex C Kwan
Journal:  Neuron       Date:  2021-07-05       Impact factor: 18.688

5.  Opposite alterations of 5-HT2A receptor brain density in subjects with schizophrenia: relevance of radiotracers pharmacological profile.

Authors:  Rebeca Diez-Alarcia; Carolina Muguruza; Guadalupe Rivero; Aintzane García-Bea; Vanessa Gómez-Vallejo; Luis F Callado; Jordi Llop; Abraham Martín; J Javier Meana
Journal:  Transl Psychiatry       Date:  2021-05-20       Impact factor: 6.222

Review 6.  Psychedelic Therapy's Transdiagnostic Effects: A Research Domain Criteria (RDoC) Perspective.

Authors:  John R Kelly; Claire M Gillan; Jack Prenderville; Clare Kelly; Andrew Harkin; Gerard Clarke; Veronica O'Keane
Journal:  Front Psychiatry       Date:  2021-12-17       Impact factor: 4.157

Review 7.  Overcoming Depression with 5-HT2A Receptor Ligands.

Authors:  Agata Zięba; Piotr Stępnicki; Dariusz Matosiuk; Agnieszka A Kaczor
Journal:  Int J Mol Sci       Date:  2021-12-21       Impact factor: 5.923

Review 8.  Psychedelics and Other Psychoplastogens for Treating Mental Illness.

Authors:  Maxemiliano V Vargas; Retsina Meyer; Arabo A Avanes; Mark Rus; David E Olson
Journal:  Front Psychiatry       Date:  2021-10-04       Impact factor: 4.157

Review 9.  Serotonergic Psychedelics in Neural Plasticity.

Authors:  Kacper Lukasiewicz; Jacob J Baker; Yi Zuo; Ju Lu
Journal:  Front Mol Neurosci       Date:  2021-10-12       Impact factor: 6.261

Review 10.  Psilocybin, a Naturally Occurring Indoleamine Compound, Could Be Useful to Prevent Suicidal Behaviors.

Authors:  Robertas Strumila; Bénédicte Nobile; Laura Korsakova; Aiste Lengvenyte; Emilie Olie; Jorge Lopez-Castroman; Sébastien Guillaume; Philippe Courtet
Journal:  Pharmaceuticals (Basel)       Date:  2021-11-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.